Modification of plasma lipoproteins by group IIA phospholipase A2 -: Possible implications for atherogenesis

被引:13
作者
Sartipy, P [1 ]
Hurt-Camejo, E [1 ]
机构
[1] Gothenburg Univ, Sahlgrens Univ Hosp, Dept Heart & Lung Dis, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden
关键词
D O I
10.1016/S1050-1738(00)00030-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present brief review summarizes some recent important studies that support the hypothesis that group IIA phospholipase A(2) may play an active role in atherogenesis. The focus of the paper is primarily on the possibility that this lipolytic enzyme may be involved in the remodeling and modification of plasma lipoproteins that may occur in the arterial wall, as well as in the circulation. In the concept of present knowledge of the hallmarks of atherogenesis, we discuss potential pathways by which changes in lipoprotein composition and physicochemical properties induced by phospholipase A(2) may contribute to initiation and progression of atherosclerosis.
引用
收藏
页码:232 / 238
页数:7
相关论文
共 68 条
  • [41] NEVALAINEN TJ, 1997, PHOSPHOLIPASE A, V2, P104
  • [42] Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the ApoB/E receptor
    Olsson, U
    Camejo, G
    HurtCamejo, E
    Elfsber, K
    Wiklund, O
    Bondjers, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) : 149 - 155
  • [43] Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins
    Olsson, U
    Bondjers, G
    Camejo, G
    [J]. DIABETES, 1999, 48 (03) : 616 - 622
  • [44] Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles -: Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans
    Öörni, K
    Hakala, JK
    Annila, A
    Ala-Korpela, M
    Kovanen, PT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 29127 - 29134
  • [45] PRUZANSKI W, 1994, J RHEUMATOL, V21, P1951
  • [46] Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries
    Romano, M
    Romano, E
    Björkerud, S
    Hurt-Camejo, E
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) : 519 - 525
  • [47] Mechanisms of disease - Atherosclerosis - An inflammatory disease
    Ross, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) : 115 - 126
  • [48] Remodelling of high density lipoproteins by plasma factors
    Rye, KA
    Clay, MA
    Barter, PJ
    [J]. ATHEROSCLEROSIS, 1999, 145 (02) : 227 - 238
  • [49] Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells
    Sakata-Kaneko, S
    Wakatsuki, Y
    Usui, T
    Matsunaga, Y
    Itoh, T
    Nishi, E
    Kume, N
    Kita, T
    [J]. FEBS LETTERS, 1998, 433 (1-2): : 161 - 165
  • [50] Binding of human phospholipase A(2) type II to proteoglycans - Differential effect of glycosaminoglycans on enzyme activity
    Sartipy, P
    Johansen, B
    Camejo, G
    Rosengren, B
    Bondjers, G
    HurtCamejo, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) : 26307 - 26314